Ontology highlight
ABSTRACT: Importance
Early neurological deterioration (END) is a critical complication in acute ischemic stroke (AIS) patients receiving intravenous thrombolysis (IVT), with a need for reliable prediction tools to guide clinical interventions.Objective
This study aimed to develop and validate a rating scale, utilizing clinical variables and multisystem laboratory evaluation, to predict END after IVT.Design setting and participants
The Clinical Trial of Revascularization Treatment for Acute Ischemic Stroke (TRAIS) cohort enrolled consecutive AIS patients from 14 stroke centers in China (Jan 2018 to Jun 2022).Outcomes
END defined as NIHSS score increase >4 points or death within 24 h of stroke onset.Results
1,213 patients (751 in the derivation cohort, 462 in the validation cohort) were included. The CNS-LAND score, a 9-point scale comprising seven variables (CK-MB, NIHSS score, systolic blood pressure, LDH, ALT, neutrophil, and D-dimer), demonstrated excellent differentiation of END (derivation cohort C statistic: 0.862; 95% CI: 0.796-0.928) and successful external validation (validation cohort C statistic: 0.851; 95% CI: 0.814-0.882). Risk stratification showed END risks of 2.1% vs. 29.5% (derivation cohort) and 2.6% vs. 31.2% (validation cohort) for scores 0-3 and 4-9, respectively.Conclusion
CNS-LAND score is a reliable predictor of END risk in AIS patients receiving IVT.
SUBMITTER: Jin H
PROVIDER: S-EPMC10552779 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
Jin Huijuan H Bi Rentang R Zhou Yifan Y Xiao Qinghui Q Li Min M Sun Shuai S Zhou Jinghua J Hu Jichuan J Huang Ming M Li Yanan Y Hong Candong C Chen Shengcai S Chang Jiang J Wan Yan Y Hu Bo B
Frontiers in neurology 20230921
<h4>Importance</h4>Early neurological deterioration (END) is a critical complication in acute ischemic stroke (AIS) patients receiving intravenous thrombolysis (IVT), with a need for reliable prediction tools to guide clinical interventions.<h4>Objective</h4>This study aimed to develop and validate a rating scale, utilizing clinical variables and multisystem laboratory evaluation, to predict END after IVT.<h4>Design setting and participants</h4>The Clinical Trial of Revascularization Treatment f ...[more]